PavmedPAVM
13F holders, Q1 2026 (March 31)20holders +17
1new positions
1sold out
$10.15avg. 13F price*
At the end of Q1 2026, 20 institutions reported holding Pavmed Inc. (PAVM) in their 13F filings, up 17 from Q4 2025. 1 opened new positions and 1 sold out. The largest holders were Two Seas Capital LP ($4.7M), First Manhattan Co. Llc. ($242K) and Geode Capital Management, LLC ($120K).
- Company
- Pavmed Inc.
- CUSIP
- 70387R502
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $4.7M |
| Exits | 1 | $14K |
All 13F filers, Q4 2025 → Q1 2026: 468,175 shares bought and 72,361 shares sold, net +395,813 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Two Seas Capital LP | 0.22% | New | 461,539 | $4.7M |
| First Manhattan Co. Llc. | 0.00% | No change | 23,805 | $242K |
| Geode Capital Management, LLC | 0.00% | Add +109.3% | 11,777 | $120K |
| Vanguard Capital Management LLC | 0.00% | — | 5,917 | $60K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 5,429 | $55K |
| BlackRock, Inc. | 0.00% | No change | 2,416 | $25K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +327.2% | 622 | $6K |
| Morgan Stanley | 0.00% | Add +2.6% | 165 | $2K |
| Cwm, LLC | 0.00% | Add +0.8% | 157 | $2K |
| UBS Group AG | 0.00% | Reduce -99.0% | 75 | $760 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -38.0% | 67 | $680 |
| Vanguard Global Advisers, LLC | 0.00% | — | 61 | $619 |
| Wells Fargo & Company | 0.00% | Reduce -17.9% | 45 | $457 |
| Allworth Financial LP | 0.00% | Add +11.8% | 6 | $61 |
| Osaic Holdings, Inc. | 0.00% | Add +48.1% | 4 | $40 |
| Group One Trading LLC | 0.00% | Add +400.0% | 2 | $20 |
| BNP Paribas Financial Markets | 0.00% | No change | 1 | $10 |
| AdvisorNet Financial, Inc | 0.00% | Reduce -80.0% | 1 | $10 |
| Steward Partners Investment Advisory, LLC | 0.00% | Add +2900.0% | 1 | $10 |
| Jones Financial Companies LLLP | 0.00% | Reduce -87.8% | 1 | $9 |
"% of holder's portfolio" is PAVM's weight in each manager's 13F, not the share of Pavmed Inc. the manager owns.